Lexus V6 Engine Fuel Leaks, Fire Risks Result in Recall of 121K Vehicles
Toyota Motor North America, Inc. is recalling more than 120,000 Lexus vehicles with V6 engines, after discovering engine components may crack over time, potentially resulting in a fuel leak and fire hazard.
The Lexus V6 engine recall was announced by the Japanese automaker on June 26, after determining that certain Lexus vehicles may start to fuel leak over time, due to the hardening of a diaphragm material in the engine. To date, Toyota is not aware of any fires or injuries resulting from the defect.
Lexus vehicles equipped with 3.5-liter V6 gasoline engines have a diaphragm that is made of a certain material that, appears to be prone to deterioration in the fuel pulsation dampers. If this happens, the components could harden and crack, allowing fuel to leak.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
The recall affects certain model year 2006 through 2013 Lexus IS 350 vehicles; 2010 through 2014 Lexus IS 350C vehicles; 2007 through 2011 Lexus GS 350 vehicles; and 2007 through 2011 Lexus GS 450h models.
According to Toyota, the recall affects about 121,000 vehicles, 115,000 of which were distributed for sale throughout the U.S. to licensed dealers.
Owners will begin receiving mailed notices in early August with instructions on how to schedule a free repair appointment at their local dealer, who will be instructed to inspect and replace the fuel delivery pipe with improved replacements.
Customers with additional questions or concerns regarding the recall can contact Toyota Customer Service at 1-800-331-4331 or visit www.toyota.com/recall to search their vehicle identification number for open and outstanding recalls.
"*" indicates required fields
More Top Stories
A Camp Lejeune non-Hodgkin's lymphoma lawsuit blames the death of a woman on her exposure to contaminated water from the military base.
Defendants want to divide the discovery process to focus on the causal links between hair relaxers and cancer.
The FDA has announced it has received 106,000 medical device reports linked to recalled Philips CPAP devices, including nearly 400 deaths.